METLIFE INC·4

Jun 18, 4:13 PM ET

Kennard William E 4

4 · METLIFE INC · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

MetLife (MET) Director William E. Kennard Receives Award of 587 Shares

What Happened

  • William E. Kennard, a non-management director of MetLife, received 587 shares of MetLife common stock on 2026-06-16 at $87.40 per share, valued at $51,304. The transaction is reported as an award/grant (code A) and represents compensation rather than an open-market purchase or sale.

Key Details

  • Transaction date and price: 2026-06-16; 587 shares at $87.40/share (total ~$51,304).
  • Transaction type/code: Award/other acquisition (A).
  • Shares owned after transaction: Not disclosed in the information provided in this summary.
  • Footnote F1: Director retainer fees are paid partly in MetLife stock; Kennard elected to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.
  • Footnote F2: The filing also references shares held in the MetLife Policyholder Trust, which holds shares allocated to eligible policyholders of a MetLife subsidiary.
  • Filing timeliness: Report filed 2026-06-18 for a 2026-06-16 transaction — no indication in the filing that it was late.

Context

  • This was a compensation award (stock issued as part of director pay) and was deferred into a director deferred compensation plan per the filing. Such awards reflect routine director compensation and are not the same signal as an open-market purchase by an insider.

Insider Transaction Report

Form 4
Period: 2026-06-16
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-16$87.40/sh+587$51,30447,410 total
Holdings
  • Common Stock

    [F2]
    (indirect: By Trust)
    10
Footnotes (2)
  • [F1]MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
  • [F2]Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.
Signature
/s/ Taylor McInerney Jansen, Attorney-in-fact|2026-06-18

Documents

1 file
  • 4
    wk-form4_1781813579.xmlPrimary

    FORM 4